Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model by Muhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao, Ruize Gao, Kris Van Moer, Akinchan Kumar, Markus Ollert, Guy Berchem, Andy Chevigné, Bassam Janji

Get full text

Biased antagonism of a series of bicyclic CXCR2 intracellular allosteric modulators by Brent Van Bosstraeten, Katrijn Boon, Max Van Hoof, Wim Dehaen, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Steven De Jonghe, Tom Van Loy

Get full text

Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3 by Sophie Bérenger, Justyna M. Adamska, Francesca Deflorian, Chris de Graaf, Christie B. Palmer, Martyna Szpakowska, Andy Chevigné, Iwan J. P. de Esch, Barbara Zarzycka, Henry F. Vischer, Maikel Wijtmans, Rob Leurs

Get full text

GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration by Dan Pascal Jean Albers, Sofya Novikova, Julio Vieyto-Nuñez, Yasser Almeida-Hernández, Chiara Pastorio, Florian Klassen, Dana Weiss, Pascal von Maltitz, Janeni Jaikishan, Moumita Datta, Hassan Jumaa, Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer, Manish Kumar, Palash Chandra Maity, Christian Buske, Ulrich Stifel, Julia Zinngrebe, Pamela Fischer-Posovszky, Andy Chevigné, Frank Kirchhoff, Elsa Sanchez-Garcia, Jan Münch, Mirja Harms

Get full text